Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.6 USD | +0.29% | -3.88% | -17.88% |
Jun. 03 | Tianqi weighs bid to protect interests in Chile's SQM-Codelco lithium deal | RE |
May. 30 | Chile's ENAMI aims to break ground on first lithium project by 2028 | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in debt and has limited leeway for investment
- With a 2024 P/E ratio at 42.01 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.88% | 13.94B | C+ | ||
+20.59% | 68.31B | A- | ||
+0.80% | 48.94B | A- | ||
+24.68% | 44.65B | B+ | ||
+29.59% | 27.81B | A- | ||
+7.78% | 19.14B | C+ | ||
+11.60% | 16.76B | B+ | ||
-5.41% | 16.05B | B+ | ||
-23.26% | 15.55B | A- | ||
-22.24% | 13.38B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALB Stock
- Ratings Albemarle Corporation